Cyproheptadine Hydrochloride Solution
Product Images NDC 70752-101

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyproheptadine Hydrochloride (NDC 70752-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quagen Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Chemsture)

FDA Label Image

Container2mg5ml (Container2mg5ml)

Container2mg5ml (Container2mg5ml)
This is a description of a medication called Cyproheptadine Hydrochloride Oral Solution, USP. Each 5 mL contains 2mg of Cyproheptadine Hydrochloride and Sorbic Acid as a preservative. The medication is manufactured by Quagen Pharmaceuticals LLC in West Caldwell, NJ. The dosage information is available in the accompanying package insert. The medication should be stored at a temperature between 20°C-25°C (68°F-77°F), with excursions to 10°C-30°C (59°F-86°F) allowed. The medication should be dispensed in a tightly sealed and light-resistant container as defined by the USP.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.